EUVIMEDEUVIMED entdecken
Crossref

A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology

Hongliang Liu, Tiantian Liu, Aiping Wang, Chao Liang iD, Xifang Zhu, Jingming Zhou, Yumei Chen, Yankai Liu, Yanhua Qi, Wenjing Chen, Gaiping Zhang

Analytical Chemistry · 2024

DOI: 10.1021/acs.analchem.4c03574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2024. Verfasst von Hongliang Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Zhengzhou University, Zhengzhou 450001, People's Republic of China. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Enzyme-Linked Immunosorbent Assay, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Zhengzhou University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingSARS-CoV-2Enzyme-Linked Immunosorbent AssaySpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2Antibodies, ViralCOVID-19AnimalsMiceHumansNeutralization TestsMice, Inbred BALB C

Substanzen

Antibodies, NeutralizingSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2spike protein, SARS-CoV-2Antibodies, ViralACE2 protein, human

Autor:innen und Institutionen

  • School of Life Sciences, Zhengzhou University, Zhengzhou 450001, People's Republic of China.
  • Longhu Laboratory, Zhengzhou 450046, People's Republic of China.
  • School of Advanced Agricultural Sciences, Peking University, Beijing 100871, People's Republic of China.

ORCID-Profile: Chao Liang

Förderung

  • National Key Research and Development Program of China
  • Zhengzhou University
  • National Natural Science Foundation of China

Zitieren

APA

Liu, H., Liu, T., Wang, A., Liang, C., Zhu, X., Zhou, J., Chen, Y., Liu, Y., Qi, Y., Chen, W., & Zhang, G. (2024). A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.4c03574

Vancouver

Liu H, Liu T, Wang A, Liang C, Zhu X, Zhou J, et al. A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology. Analytical Chemistry. 2024. doi:10.1021/acs.analchem.4c03574

BibTeX
@article{Liu2024,
  author = {Liu, Hongliang and Liu, Tiantian and Wang, Aiping and Liang, Chao and Zhu, Xifang and Zhou, Jingming and Chen, Yumei and Liu, Yankai and Qi, Yanhua and Chen, Wenjing and Zhang, Gaiping},
  title = {A Novel Cell- and Virus-Free SARS-CoV-2 Neutralizing Antibody ELISA Based on Site-Specific Labeling Technology},
  journal = {Analytical Chemistry},
  year = {2024},
  doi = {10.1021/acs.analchem.4c03574}
}
Kostenlos starten →